These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 3464449

  • 1. Staging of leukemic progenitor cells in acute myeloid leukemia by phenotyping with myeloid monoclonal antibodies.
    Hast R, Dowding C, Robak T, Goldman JM.
    Exp Hematol; 1986 Nov; 14(10):981-7. PubMed ID: 3464449
    [Abstract] [Full Text] [Related]

  • 2. Antigenic phenotype of chronic granulocytic leukaemia progenitor cells in chronic phase and in blastic transformation characterized by means of monoclonal antibodies.
    Robak T.
    Arch Immunol Ther Exp (Warsz); 1988 Nov; 36(4):471-85. PubMed ID: 3074744
    [Abstract] [Full Text] [Related]

  • 3. Application of monoclonal antibodies in the antigenic characteristics of normal myeloid progenitor cells and clonogenic blasts in acute myeloid leukaemia.
    Robak T.
    Arch Immunol Ther Exp (Warsz); 1988 Nov; 36(1):71-84. PubMed ID: 3233065
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Classification of acute myeloid leukemias--a comparison of FAB and immunophenotyping.
    Drexler HG.
    Leukemia; 1987 Oct; 1(10):697-705. PubMed ID: 3312833
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antigenic characteristics of circulating granulocyte-macrophage progenitors (CFU-GM) in idiopathic myelofibrosis and polycythaemia vera defined by monoclonal antibodies.
    Robak T.
    Arch Immunol Ther Exp (Warsz); 1989 Oct; 37(1-2):17-28. PubMed ID: 2619501
    [Abstract] [Full Text] [Related]

  • 9. Expression of myeloid differentiation antigens on normal and chronic granulocytic leukemia erythroid progenitor cells identified by monoclonal antibodies.
    Robak T.
    Arch Immunol Ther Exp (Warsz); 1987 Oct; 35(4):519-29. PubMed ID: 3481543
    [Abstract] [Full Text] [Related]

  • 10. Antigenic determinants on myeloid leukaemia colony-forming cells resemble those of normal myeloid progenitor cells and differ from those of circulating blast cells.
    Robak T, Dowding C, Garewal G, Hibbin JA, Th'ng KH, Goldman JM.
    Br J Haematol; 1986 Sep; 64(1):133-48. PubMed ID: 2428394
    [Abstract] [Full Text] [Related]

  • 11. Phenotyping of acute myelocytic leukemia (AML) progenitors: an approach for tracing minimal numbers of AML cells among normal bone marrow.
    Delwel R, van Gurp R, Bot F, Touw I, Löwenberg B.
    Leukemia; 1988 Dec; 2(12):814-9. PubMed ID: 3199876
    [Abstract] [Full Text] [Related]

  • 12. A modern classification of the acute non-lymphoblastic leukaemias.
    Hayhoe FG.
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():70-2. PubMed ID: 2653522
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M, Hecht K, Reif S, Pelka-Fleischer R, Pfister K, Schmetzer H.
    Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
    [Abstract] [Full Text] [Related]

  • 15. Heterogeneity of clonogenic cells in acute myeloblastic leukemia.
    Sabbath KD, Ball ED, Larcom P, Davis RB, Griffin JD.
    J Clin Invest; 1985 Feb; 75(2):746-53. PubMed ID: 3855866
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antigenic characteristics of erythropoietin dependent and independent erythroid progenitors (BFU-E and CFU-E) in polycythaemia vera and idiopathic myelofibrosis defined by monoclonal antibodies.
    Robak T.
    Arch Immunol Ther Exp (Warsz); 1988 Feb; 36(6):733-47. PubMed ID: 3254121
    [Abstract] [Full Text] [Related]

  • 18. Antibody dependent cellular cytotoxicity and complement mediated cytotoxicity on leukemic cells mediated by anti K562 monoclonal antibodies.
    Tatake RJ, Maniar HS, Chiplunkar SV, Somasundaram R, Amin MK, Saikia T, Gangal SG.
    J Clin Lab Immunol; 1990 Feb; 31(2):87-91. PubMed ID: 1966990
    [Abstract] [Full Text] [Related]

  • 19. Vim-2, candidate monoclonal antibody for purging autologous marrow grafts in acute myeloblastic leukaemia.
    Delwel R, Bot F, Knapp W, Löwenberg B.
    Bone Marrow Transplant; 1987 Aug; 2(2):149-54. PubMed ID: 3332163
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.